← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 382개
CGTBiologicstaleChinese PLA General HospitalPhase 2

anti-CD20-CAR vector-transduced autologous T cells (anti-CD20-CAR vector-transduced autologous T cells)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · CD20

#CD20#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
CGTBiologicstaleXinqiao Hospital of ChongqingPhase 1

anti-CD33 CAR NK cells (anti-CD33 CAR NK cells)

Leukemia, Myeloid, Acute · CD33

#CD33#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
CGTBiologicstaleChinese PLA General HospitalPhase 2

anti-CD33 CART (anti-CD33 CART)

Relapsed Adult Myeloid Leukemia; Chemotherapy Refractory Adult Myeloid Leukemia · CD33

#CD33#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai General Hospital, Shan…Phase 1

anti-CD7 CAR-T cells (anti-CD7 CAR-T cells)

T Lymphoblastic Leukemia/Lymphoma; T-cell Acute Lymphoblastic Leukemia · T Lymphoblastic Leukemia/Lymphoma

#TLymphoblasticLeukemiaLymphoma#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
CGTBiologicstaleThe First Affiliated Hospital o…Phase 2

anti-CLL1 CART (anti-CLL1 CART)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 2

anti-FLT3 CAR-T (anti-FLT3 CAR-T)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleAmgenPhase 1

blinatumomab and auto-HSCT "sandwich " strategy (blinatumomab and auto-HSCT "sandwich " strategy)

B-cell Acute Lymphoblastic Leukemia · B-cell Acute Lymphoblastic Leukemia

#B-cellAcuteLymphoblasticLeukemia#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystalePfizerPhase 3

gemtuzumab ozogamycin (gemtuzumab ozogamycin)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai iCELL Biotechnology Co…Phase 1

haploid allogeneic NK cell therapy (haploid allogeneic NK cell therapy)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleUniversity of PennsylvaniaPhase 1

huCART19 Cells (huCART19 Cells)

Chemotherapy Resistant Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBlueWhale Bio (Cohort D only)Phase 1

huCART19-IL18 (huCART19-IL18)

Chronic Lymphocytic Leukemia; Non-hodgkin Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleZhujiang HospitalPhase 1

humanized CD19 CAR-T Cells with TLR2 (humanized CD19 CAR-T Cells with TLR2)

B Lymphoblastic Leukemia/Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleGuangzhou Ruixin Biotechnologic…Phase 1

iNK cells (iNK cells)

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 58.7%임상시험 1상태 RECRUITING
AntibodystaleGruppo Italiano Malattie EMatol…Preclinical

idelalisib and rituximab (idelalisib and rituximab)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstalePfizerApproved

inotuzumab ozogamicin-dose level 2 (inotuzumab ozogamicin-dose level 2)

Leukemia; Precursor b-Cell Lymphoblastic Leukemia-Lymphoma · Leukemia

#Leukemia#ADC#Approved#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 1

pCAR-19B cells (pCAR-19B cells)

Acute Lymphoblastic Leukemia, in Relapse; Refractory Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
ADCBiologicstaleNew York Medical CollegePhase 1

pralatraxate, (pralatraxate,)

NK-Cell Lymphoma; NK-Cell Leukemia · NK-Cell Lymphoma

#NK-CellLymphoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleShenzhen Geno-Immune Medical In…Phase 1

prophylactic 4SCAR19 cells (prophylactic 4SCAR19 cells)

B Acute Lymphoblastic Leukemia · B Acute Lymphoblastic Leukemia

#BAcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

rituximab, methylprednisolone (rituximab, methylprednisolone)

Chronic B-Lymphocytic Leukemia · Chronic B-Lymphocytic Leukemia

#ChronicB-LymphocyticLeukemia#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleThe First Affiliated Hospital o…Phase 2

ssCART-19 cells combined with CD19+ feeding T cells (FTCs, ssCART-19 cells combined with CD19+ feeding T cells, ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion)

Acute Lymphoblastic Leukemia, Adult B-Cell · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING

19 / 20 페이지

← 이전다음 →